Relationship Between Maternal Bone Biomarkers and Fetal Adiposity Through Normal Pregnancy | Zendy

George Mastorakos | Zendy; Dimosthenis Maliopoulos | Zendy; Spyridoula Kasioni | Zendy; Αlexandra Bargiota | Zendy; Thomas M. Barber | Zendy; Chrysanthi Skevaki | Zendy; Ioannis Papassotiriou | Zendy; Nikos Vrachnis | Zendy; George Farmakides | Zendy; Nikolaos Vlahos | Zendy; Sudhesh Kumar | Zendy; Georgios Valsamakis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Relationship Between Maternal Bone Biomarkers and Fetal Adiposity Through Normal Pregnancy

Author(s) -

George Mastorakos,

Dimosthenis Maliopoulos,

Spyridoula Kasioni,

Αlexandra Bargiota,

Thomas M. Barber,

Chrysanthi Skevaki,

Ioannis Papassotiriou,

Nikos Vrachnis,

George Farmakides,

Nikolaos Vlahos,

Sudhesh Kumar,

Georgios Valsamakis

Publication year - 2021

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/clinem/dgab152

Subject(s) - medicine , fetus , endocrinology , sclerostin , pregnancy , adipose tissue , birth weight , obstetrics , biology , wnt signaling pathway , biochemistry , genetics , gene

To examine the association of maternal bone markers [sclerostin, soluble receptor activator of nuclear factor-κB ligand (sRANKL), osteocalcin, 25-hydroxyvitamin D3] with fetal intra-abdominal and subcutaneous adipose tissue deposition and birthweight during normal pregnancy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research